Ending Sexual Harassment - Teaching Of Principal Investigators (E-STOP)

April 16, 2024 updated by: Arghavan Salles, Stanford University
The study targets three aims: Aim 1: focuses on PIs' and mentors' confidence in their ability to intervene on sexual harassment and their attitudes, perceptions, and knowledge (APK) about sexual harassment, civility, microaggressions, and unconscious bias. Aim 2: focuses on trainees' experiences of sexual harassment and microaggressions and civility, sense of belonging, well-being, productivity, and persistence in a research career. Aim 3: focuses on the culture and climate of the research learning environment.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

Participants (PIs, mentors, and trainees), starting in year one, will be asked to complete a baseline survey (using the secure survey software Qualtrics) regardless of condition assignment. Then, for nine months, PIs, mentors, and mentees will receive virtual educational materials (presented using a Learning Management System) appropriate to the condition to which their program has been randomized.

The initial post-survey for PIs and mentors will be integrated into the final module to evaluate short-term outcomes, encompassing attitudes, perceptions, and knowledge. Subsequently, the second post-survey will be administered one year later. Trainees will participate in three post-surveys: one immediately after, another one year later, and a final one two years later.

Study Type

Interventional

Enrollment (Estimated)

2160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Stanford, California, United States, 94305
        • Stanford University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • PIs, Mentors and Trainees of T-32 Programs

Exclusion Criteria:

  • People who are not PIs, Mentors and Trainees of T-32 Programs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group / year 1
Beginning in year 1, participants access online video modules through an online learning platform for up to 9 months.
Behavioral: E-STOP online educational program (treatment condition)
Participants access online video modules through an online learning platform. Program includes modules on civility and upstander interventions and education about sexual harassment, microaggressions, and implicit bias.
Experimental: Control Condition Group / year 1
Beginning in year 1, participants access online video modules through an online learning platform for up to 9 months.
Behavioral: E-STOP online educational program (control condition)
Participants access online video modules through an online learning platform. Program includes authorship ethics only.
Experimental: Intervention Group / year 2
Beginning in year 2, participants access online video modules through an online learning platform for up to 9 months.
Behavioral: E-STOP online educational program (treatment condition)
Participants access online video modules through an online learning platform. Program includes modules on civility and upstander interventions and education about sexual harassment, microaggressions, and implicit bias.
Experimental: Control Condition Group / year 2
Beginning in year 2, participants access online video modules through an online learning platform for up to 9 months.
Behavioral: E-STOP online educational program (control condition)
Participants access online video modules through an online learning platform. Program includes authorship ethics only.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Confidence to Intervene on Sexual Harassment Scale Score
Time Frame: Survey at baseline, immediately post-intervention (9 months after baseline), and 1 year after the completion of the 9-month intervention
Participants are asked to rate: "How confident are you in your ability to intervene when you hear about or witness sexual harassment?" Score range: 1 (not at all confident) to 5 (extremely confident).
Survey at baseline, immediately post-intervention (9 months after baseline), and 1 year after the completion of the 9-month intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Persistence in research careers
Time Frame: baseline, immediately post-intervention (9 months after baseline), and 1 year after completion of the 9-month intervention.
Participants are asked to rate: "How extensively do you expect to be involved in research during your medical career?" Score range 1 (not involved) to 5 (exclusively)
baseline, immediately post-intervention (9 months after baseline), and 1 year after completion of the 9-month intervention.
Experiences of sexual harassment as measured by the short Sexual Experiences Questionnaire (SEQ-DoDs)
Time Frame: baseline, immediately post-intervention (9 months after baseline), and 1 year after completion of the 9-month intervention.
The SEQ consists of 4 domains: gender harassment--sexist hostility (4 questions); gender harassment--sexual hostility (4 questions); unwanted sexual attention (4 questions); and sexual coercion (4 questions); the score for each question ranges from 1 (never) to 5 (many times); scores for questions within each domain are summed and divided by the number of questions, resulting in an average score range from 1 (never) to 5 (many times) for each domain.
baseline, immediately post-intervention (9 months after baseline), and 1 year after completion of the 9-month intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Stanford University

Collaborators

National Institute of General Medical Sciences (NIGMS)

Investigators

  • Principal Investigator: Arghavan Salles, arghavan@stanford.edu

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2024

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

December 6, 2023

First Submitted That Met QC Criteria

December 6, 2023

First Posted (Actual)

December 14, 2023

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 66842
  • 1R01GM147063 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Harassment

Clinical Trials on E-STOP online educational program (treatment condition)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe